<DOC>
	<DOCNO>NCT01781195</DOCNO>
	<brief_summary>Prolonged-release low-dose Advagraf well protect CNI-side effect compare standard immunosuppressive regiment rate rejection increase thus graft function well maintain . We hypothesize especially high-MELD ( MELD-score &gt; 20 ) recipient decrease immune competence prolonged-release low-dose Advagraf concept would better protect side effect immunosuppression ( i.e . infection ) . Nevertheless , assume also patient MELD-score â‰¤20 benefit concept regard low infection rate less side effect immunosuppression .</brief_summary>
	<brief_title>Delayed CNI-based Immunosuppression With Advagraf After MELD-based Liver Transplantation</brief_title>
	<detailed_description>The MELD-score ( model end stage liver disease ) design estimate prognosis TIPS ( transjugular intrahepatic porto-systemic shunt ) . Nowadays key-score patient await liver graft consist serum-creatinine , serum-bilirubine INR-ratio value 6-40 . The MELD-based liver allocation follow sick patient first strategy significantly decrease outcome liver transplantation ( LTx ) Germany . There evidence immune competence sick patient decrease . Monocytic HLA-DR status marker function immune system . A reduced monocytic HLA-DR expression indicative suppress immune system . Blood level Advagraf slowly increase first week aim tacrolimus trough level reach . Since therapeutic tacrolimus trough level reach end first week transplantation concept prolonged-release immunosuppression . We assume , high-MELD patient ( MELD &gt; 20 ) undergo LTx immunosuppressed per se . Thus prolonged-release low-dose immunosuppression Advagraf would decrease both- infection rate ( CMV-reactivation , wound infection urinary tract infection , pneumonia , etc . ) side effect immunosuppression . The immune capacity patient determine measurement monocytic HLA-DR status . To ensure graft function impair due rejection episode , liver function determine LiMAx-test , routine procedure institution . After 13-C-Methacetin give patient , metabolize paracetamol 13CO2 enzyme CYP1A2 localize hepatocytes . The 13CO2/12CO2 ratio exhale air correlate liver function .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>age &gt; 18 , &lt; 65 first liver transplantation Immunosuppression Advagraf , MMF , corticosteroid surgery postoperative treatment department general , visceral transplantation surgery miss inform consent retransplantation acute infection : CMV ( pp65 positive ) , pneumonia , urinary tract infection , wound infection , reactivation Hepatitis B/C</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Advagraf</keyword>
	<keyword>MELD-score</keyword>
	<keyword>Na-MELD-score</keyword>
	<keyword>liver function</keyword>
	<keyword>LiMAx-test</keyword>
	<keyword>infection rate</keyword>
	<keyword>HLA-DR status</keyword>
	<keyword>immunostatus</keyword>
</DOC>